For patients, visible symptoms of uveitis correlate with perceptions of worse physical health, according to a recent study. Ophthalmologist Sunil Srivastava, MD, and rheumatologists Rula Hajj-Ali, Joshua Hedrick, MD, explain the relationship between patient reported outcomes measures and disease activity in inflammatory eye disease.
A new study of long-term outcomes in primary angiitis of the central nervous system suggests that mortality is significant, but long-term disability is mild. Dr. Rula Hajj-Ali describes her research efforts and the need for prognostic markers.
Primary immunodeficiency disorders (PID) have a growing spectrum of noninfectious complications. Vasculitis is one. Here’s what rheumatologists should take away from recent research.
This case series adds to the diagnostic landscape of CNS granulomatous disease and provides an overview of the varying treatments currently in use for these rare manifestations of a rare disease.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
This is the longest reported follow-up of patients with PACNS and the first evaluation of the quality of life and incidence of depression in these patients.
A training infrastructure for our rheumatology fellows provides a full circle experience of evidence-based, didactic learning and its application to the direct care of patients with vasculitis.
Uveitis accounts for 10-15 percent of legal blindness in the United States. At Cleveland Clinic, multicenter collaboration, fast-track evaluation and treatment help patients avoid vision loss.
An international collaborative study and disease registry are among an array of efforts led out of Cleveland Clinic to better understand and manage this rare autoimmune disease.
A comprehensive suite of 30 free CME webcasts gives you the chance to see why clinicians came from 29 states and 20 nations to attend this year’s Biologic Therapies Summit VI.
This daylong pre-symposium to Cleveland Clinic’s Biologic Therapies VI Summit is the most comprehensive live CME course to date on this complex vascular inflammatory disease.